A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Jazz Pharmaceuticals
Daiichi Sankyo
ImmunityBio, Inc.
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.
University of California, Irvine
Azienda USL Reggio Emilia - IRCCS
Tongji Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Erasmus Medical Center
Universitair Ziekenhuis Brussel
pharmaand GmbH
Ellipses Pharma
Kyunghee University Medical Center
MultiVir, Inc.
Eli Lilly and Company
Roswell Park Cancer Institute
National University Hospital, Singapore
Roger Williams Medical Center
National Cancer Institute (NCI)
Georgetown University
The University of Texas Health Science Center, Houston
National Institutes of Health Clinical Center (CC)
Adherex Technologies, Inc.